• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板功能分析仪(PFA-100/200)在排除或检测血管性血友病中的作用:一项历经 22 年的研究。

Utility of the platelet function analyser (PFA-100/200) for exclusion or detection of von Willebrand disease: A study 22 years in the making.

机构信息

Haematology, Institute of Clinical Pathology and Medical Research (ICPMR), NSW Health Pathology, Westmead Hospital, Westmead, NSW, Australia; Sydney Centres for Thrombosis and Haemostasis Research, Westmead Hospital, Westmead, NSW, Australia.

出版信息

Thromb Res. 2020 Apr;188:17-24. doi: 10.1016/j.thromres.2020.01.029. Epub 2020 Feb 1.

DOI:10.1016/j.thromres.2020.01.029
PMID:32036157
Abstract

INTRODUCTION

von Willebrand disease (VWD) is the most common inherited bleeding disorder and may alternatively arise as an acquired condition (AVWS). These represent deficiency and/or defects in von Willebrand factor (VWF). Closure times (CTs) obtained from the platelet function analyser (PFA) are highly sensitive to both VWD/AVWS. The current study has evaluated the utility of the PFA-100/-200 to exclude or detect laboratory identified VWD.

MATERIALS AND METHODS

An evaluation of the success or otherwise of prospective PFA testing to help exclude or detect VWD using data from a locally maintained database. This database contains patient information, results of PFA testing, results of VWF testing, platelet count and hematocrit, and additional information, for a current total of 3678 entries representing over 2 decades of testing.

RESULTS

According to selection criteria, a total of 142 samples were identified as derived from patients with VWD. All but one of these were also identified to have abnormal PFA CTs. Additional data sets of patients with 'low VWF' (n = 137), or borderline normal VWF (n = 163) were also identified, as well as patients with thrombocytopenia and/or low hematocrit (n = 487). In these cohorts, PFA CTs were often (but not always) abnormal. There was a strong association between VWF test parameter values and PFA CTs. Additional study samples comprised cases with normal VWF parameters but prolonged CTs (n = 594), as well as cases with normal VWF and normal CTs (n = 1292), permitting calculation of sensitivity of abnormal PFA for VWD (99.3%), as well as specificity (68.5%), negative predictive value (99.9%) and positive predictive value (19.2%), for a prevalence of 7.0%. Comparatively, normal PFA CTs were better able to exclude VWD than normal test results for individual VWF parameters.

CONCLUSION

This study reports on an evaluation of PFA CTs for identification or exclusion of VWD. In our dataset, representing over 22 years of experience, normal PFA CTs were able to predict absence of VWD with higher sensitivity than individual VWF test results.

摘要

简介

血管性血友病(VWD)是最常见的遗传性出血性疾病,也可作为获得性疾病(AVWS)出现。这些表现为血管性血友病因子(VWF)的缺乏和/或缺陷。从血小板功能分析仪(PFA)获得的闭合时间(CT)对 VWD/AVWS 高度敏感。本研究评估了 PFA-100/-200 在排除或检测实验室鉴定的 VWD 方面的效用。

材料和方法

对前瞻性 PFA 检测的成功与否进行评估,以帮助使用本地维护的数据库中的数据排除或检测 VWD。该数据库包含患者信息、PFA 检测结果、VWF 检测结果、血小板计数和血细胞比容以及其他信息,目前总共有 3678 项代表超过 20 年的检测。

结果

根据选择标准,共确定 142 个样本来自 VWD 患者。除 1 个样本外,所有样本的 PFA CT 均异常。还确定了具有“低 VWF”(n=137)或边界正常 VWF(n=163)的其他数据集,以及血小板减少症和/或低血细胞比容的患者(n=487)。在这些队列中,PFA CT 通常(但不总是)异常。VWF 测试参数值与 PFA CT 之间存在很强的关联。额外的研究样本包括 VWF 参数正常但 CT 延长的病例(n=594),以及 VWF 和正常 CT 的病例(n=1292),可计算异常 PFA 对 VWD 的敏感性(99.3%),特异性(68.5%),阴性预测值(99.9%)和阳性预测值(19.2%),患病率为 7.0%。相比之下,正常的 PFA CT 能够比单个 VWF 参数的正常测试结果更好地排除 VWD。

结论

本研究报告了对 PFA CT 用于识别或排除 VWD 的评估。在我们的数据集(代表超过 22 年的经验)中,正常的 PFA CT 能够以比单个 VWF 测试结果更高的敏感性预测 VWD 的不存在。

相似文献

1
Utility of the platelet function analyser (PFA-100/200) for exclusion or detection of von Willebrand disease: A study 22 years in the making.血小板功能分析仪(PFA-100/200)在排除或检测血管性血友病中的作用:一项历经 22 年的研究。
Thromb Res. 2020 Apr;188:17-24. doi: 10.1016/j.thromres.2020.01.029. Epub 2020 Feb 1.
2
Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders.使用对血管性血友病因子紊乱具有高敏感性的新型血小板功能分析仪(PFA - 100)来筛查血管性血友病及其他病症。
Am J Hematol. 1999 Nov;62(3):165-74. doi: 10.1002/(sici)1096-8652(199911)62:3<165::aid-ajh6>3.0.co;2-c.
3
von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.基于儿科人群的血管性血友病——1型诊断标准及血小板功能分析仪-100和血管性血友病因子/胶原结合试验应用的比较
Thromb Haemost. 2000 Sep;84(3):401-9.
4
PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2.1型和2型血管性血友病中,使用PFA-100监测血管性血友病因子(VWF)对去氨加压素(DDAVP)的反应以及VIII因子/VWF浓缩物替代治疗的效果
Thromb Haemost. 2008 Sep;100(3):462-8.
5
Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF:CBA as combined diagnostic strategies.血管性血友病(vWD)的实验室诊断及去氨加压素(DDAVP)治疗监测:血小板功能分析仪-100(PFA-100)和血管性血友病因子:胶原结合试验(vWF:CBA)联合诊断策略的有效性
Haemophilia. 2001 Mar;7(2):180-9. doi: 10.1046/j.1365-2516.2001.00487.x.
6
High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.高分辨率多聚体分析和PFA-100血小板功能分析仪能够在血管性血友病因子辅因子活性与血管性血友病因子抗原水平无病理比值的情况下检测出2A型血管性血友病。
Clin Lab. 2012;58(11-12):1203-9.
7
Laboratory characterization of obligate carriers of type 3 von Willebrand disease with a potential role for Platelet Function Analyzer (PFA-200).血小板功能分析仪(PFA-200)在 3 型血管性血友病必需携带者的实验室特征分析中的潜在作用
Int J Lab Hematol. 2022 Jun;44(3):603-609. doi: 10.1111/ijlh.13787. Epub 2022 Jan 5.
8
Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.血管性血友病治疗的实验室监测:PFA-100及血管性血友病因子与胶原结合活性作为联合策略的疗效
Semin Thromb Hemost. 2006 Sep;32(6):566-76. doi: 10.1055/s-2006-949662.
9
Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function.结合全血血小板聚集和功能对历史 von Willebrand 病诊断进行全面再评估。
Int J Lab Hematol. 2018 Jun;40(3):304-311. doi: 10.1111/ijlh.12785. Epub 2018 Feb 10.
10
Sensitive and specific assessment of recombinant von Willebrand factor in platelet function analyzer.血小板功能分析仪中重组血管性血友病因子的敏感和特异性评估。
Platelets. 2019;30(2):264-270. doi: 10.1080/09537104.2017.1420153. Epub 2018 Jan 10.

引用本文的文献

1
Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review.原发性止血遗传性疾病患者的即时检验:一项叙述性综述。
Semin Thromb Hemost. 2025 Jun;51(5):541-559. doi: 10.1055/s-0044-1787976. Epub 2024 Jul 1.
2
Extracorporeal Membrane Oxygenation (ECMO)-Associated Coagulopathy in Adults.成人体外膜肺氧合(ECMO)相关凝血病
Diagnostics (Basel). 2023 Nov 21;13(23):3496. doi: 10.3390/diagnostics13233496.
3
Perioperative Considerations in Management of the Severely Bleeding Coagulopathic Patient.
严重出血性凝血功能障碍患者的围手术期处理注意事项。
Anesthesiology. 2023 May 1;138(5):535-560. doi: 10.1097/ALN.0000000000004520.
4
Harmonizing platelet function analyzer testing and reporting in a large laboratory network.在大型实验室网络中协调血小板功能分析仪检测和报告。
Int J Lab Hematol. 2022 Oct;44(5):934-944. doi: 10.1111/ijlh.13907. Epub 2022 Jun 26.
5
Multiparameter platelet function analysis of bleeding patients with a prolonged platelet function analyser closure time.对血小板功能分析仪关闭时间延长的出血患者进行多参数血小板功能分析。
Br J Haematol. 2022 Mar;196(6):1388-1400. doi: 10.1111/bjh.18003. Epub 2022 Jan 10.
6
Variables that Influence Platelet Function Analyzer-100™ Closure Times in Healthy Algerian Adults.影响健康阿尔及利亚成年人血小板功能分析仪-100™ 关闭时间的变量。
Int J Appl Basic Med Res. 2021 Jul-Sep;11(3):154-159. doi: 10.4103/ijabmr.IJABMR_532_20. Epub 2021 Jul 19.
7
Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200.强效且快速逆转血管性血友病因子抑制剂适配体BT200。
J Thromb Haemost. 2020 Jul;18(7):1695-1704. doi: 10.1111/jth.14822. Epub 2020 Jun 10.